[Zosteriform cutaneous leiomyoma. Satisfactory treatment with oral doxazosin].
We report a 50-year-old man that presented a zosteriform cutaneous leiomyoma in the left facial region, intensely painful, that showed great improvement after the administration of a daily dose of 4 mg of oral doxasozin. The therapy was well tolerated and did not present any associated adverse effect. In the English medical literature only two cases successfully treated with doxasozin have been reported.
Chaves
A J
AJ
Unidad de Dermatología, Hospital Universitario Infanta Cristina, Badajoz, España. antoniojchaves@yahoo.es
Fernández-Recio
J M
JM
de Argila
D
D
Rodríguez-Nevado
I
I
Catalina
M
M
D000284:Administration, Oral; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D017292:Doxazosin / Q000494:pharmacology / Q000627:therapeutic use*; D005153:Facial Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D006562:Herpes Zoster / Q000175:diagnosis; D006801:Humans; D007889:Leiomyoma / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010863:Piloerection / Q000187:drug effects; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D017292:Doxazosin